Pacific Vascular purchases Toshiba's Aplio 300 ultrasound systems

NewsGuard 100/100 Score

Pacific Vascular, Inc. is providing its patients with the latest in ultrasound technology by acquiring 36 AplioTM 300 ultrasound systems from Toshiba America Medical Systems, Inc. Across 12 facilities in Washington, Toshiba recently completed extensive training with Pacific Vascular staff and customized multiple protocols and measurements for their vascular imaging needs.

"We were in the process of going completely digital and wanted to upgrade our ultrasound systems with a single platform," said Bonnie Brown, technical director, Pacific Vascular. "After reviewing several other ultrasound systems on the market, we knew the Aplio 300 was the right choice, because it's easy to use and produces excellent vascular image quality. Toshiba's partnership approach also gave us the service, support and training we needed to be up and running right away."

The Aplio 300 offers exceptional industry-leading depth and detail in a smaller, versatile platform for all routine cardiovascular ultrasound exams. It comes standard with advanced workflow tools and ergonomics, including the iStyleTM+ Productivity Suite, enabling efficient and precise exams.

"Hospitals and imaging centers are looking for more than just advanced imaging technology as they navigate through health reform," said Tomohiro Hasegawa, director, Ultrasound Business Unit, Toshiba. "They need a long-term partner offering customized training, education and service to give them a worry-free experience so they can focus on what matters most, which is caring for their patients."

Toshiba will showcase the Aplio 300 ultrasound system at this year's American College of Cardiology (ACC) annual meeting in Washington, D.C., March 29-April 2, 2014 (Booth #2323).

Source:

Toshiba America Medical Systems, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Vaccines targeting chronic diseases show promise in combatting age-related conditions